Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.860,01
-0,33%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Gsk Plc (GSK) Gsk Plc (GSK) Notizie

GSK

Gsk (GSK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
DataOraFonteTitoloSimboloCompagnia
17/05/202410:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202408:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
16/05/202418:13Alliance NewsAlliance NewsTOP NEWS: GSK to sell remaining holding in spin-off HaleonLSE:GSKGsk Plc
16/05/202417:42RNS Regulatory NewsGSK PLC GSK announces intention to sell shares in HaleonLSE:GSKGsk Plc
14/05/202416:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
13/05/202416:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
08/05/202419:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202417:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
01/05/202416:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202409:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202409:59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202408:00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202411:27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202413:05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202414:00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202417:20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202410:30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202409:47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
07/03/202410:38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202408:00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202417:00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202418:24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202412:03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK

La tua Cronologia

BIT
I08084
Intesa Sanpaolo
ASX
EMUCA
Emu NL
BIT
I06808
Intesa Sanpaolo
LSE
GCP
Gcp Infrastructure Inves...
BIT
WOSA25
OSAI Automation System
ASX
EX1
Exopharm
NASDAQ
CWBS
LSE
NUOG
Nu-oil And Gas
BIT
I07863
Intesa Sanpaolo
ASX
VOC
Vocus
ASX
EGF
Evans and Partners Globa...
ASX
ESHO
Esports Mogul
BIT
S29091
Societe Generale Effekten
ASX
ERD
EROAD
NYSE
IIM
Invesco Value Municipal ...
NYSE
DCA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network